Skip to search.
 FTSE 100 Up 0.35%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
454.50 27 Mar 20:00
|Pre-Market : 459.45 Up 4.95 (1.09%) 13:55 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:454.50
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:450.26
Beta:0.69
Earnings Date:6 May - 11 May (Est.)
Day's Range:N/A - N/A
52wk Range:269.50 - 495.50
Volume:0
Avg Vol (3m):885,495
Market Cap:46.31b
P/E (ttm):148.05
EPS (ttm):3.07
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGN 0.00%46.31b
AMGN123.38b
NVS240.82b
RHHBYN/A

Key Statistics

Forward P/E (1 yr):35.90
P/S (ttm):16.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :10.90
Quarterly EPS Est (Mar-15) :2.69
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback